BKE insider files Form 144 to sell 6,000 shares via UBS on NYSE
Rhea-AI Filing Summary
The filer plans to sell 6,000 shares of The Buckle, Inc. common stock through UBS Financial Services on the NYSE, with an approximate aggregate market value of $360,414.15 and an approximate sale date of 09/05/2025. The filing shows the shares were acquired as restricted stock awards from Buckle Inc: 4,962 shares granted 01/30/2021 and 1,038 shares granted 03/25/2024. The filing reports 51,160,000 shares outstanding for the issuer and states there were no sales by the filer in the past three months. The notice includes the required representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Positive
- Clear compliance details: the Form 144 identifies broker, share counts, acquisition dates, and nature of acquisition (restricted stock awards).
- No recent sales reported: the filer reports "Nothing to Report" for securities sold in the past three months.
- Seller representation included: the notice contains the required statement that the seller is not aware of undisclosed material adverse information.
Negative
- None.
Insights
TL;DR: Routine Rule 144 notification for an executive or insider selling vested restricted stock on the open market.
The filing documents a proposed Rule 144 sale of 6,000 Buckle, Inc. (BKE) common shares via UBS on the NYSE with an indicated aggregate market value of $360,414.15 and an approximate sale date of September 5, 2025. The shares were acquired as restricted stock awards in 2021 and 2024, which explains the use of Rule 144 for public resale. No sales in the prior three months are reported, suggesting this notice covers a planned, discrete disposition rather than a recurring program disclosed here.
TL;DR: Compliance-oriented filing showing an insider meeting Rule 144 disclosure requirements; no red flags in the notice itself.
The Form 144 conveys the seller's representation about absence of material nonpublic information and identifies the broker, share counts, grant dates, and nature of acquisition (restricted stock awards). These elements satisfy the public-disclosure expectations for an insider sale under Rule 144. The notice does not provide further corporate or governance context beyond the required transactional details.